Drug Database
Back to search

United States· US:62135-973_2732839a-191a-570f-e063-6294a90a40a4

Mefloquine Hydrochloride

A mefloquine product containing mefloquine hydrochloride, registered in United States by Chartwell RX, LLC. The same ATC class is registered in 9 of our 19 countries.

ATC P01BC02US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedMefloquine HydrochlorideATCP01BC02REGISTER NO.US:62135-973_2732839a…PACKS LISTED4CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about mefloquine hydrochlorideAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Mefloquine is registered in 9 of 19 countries.

Countries holding a registration under ATC P01BC02 (mefloquine), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 5 of them publish a price we can compare per daily dose
Search mefloquine products by name

Mefloquine · ATC P01BC02

9 / 19 countries

  • Belgiumprice
  • Canada
  • Finlandprice
  • Japan
  • Netherlands
  • Norwayprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
MEFLOQUINE HYDROCHLORIDE
Manufacturer
Chartwell RX, LLC
Country
United States (US)
ATC code
P01BC02
ATC class
Mefloquine
Defined daily dose
1 g, O
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 4

  • ndc11
    62135-973-25
  • ndc11
    62135-973-11
  • ndc11
    6213597311
    5 TABLET in 1 BOTTLE (62135-973-11)
  • ndc11
    6213597325
    25 TABLET in 1 BOTTLE (62135-973-25)

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

439 interactions on record for mefloquine.

Graded by severity as the source publishes them — 82 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check mefloquine against other medicinesHow interaction checks work

Mefloquine · interactions on record

439 records

  • 82 severe
  • 338 moderate
  • 8 minor
  • 11 info

Most severe, free to view

  • PapaverineA03AD01severe
  • CisaprideA03FA02severe
  • DolasetronA04AA04severe
  • ProcainamideC01BA02severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Mefloquine in 10 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All mefloquine products

Authorised across Europe · EMA

The same active substance is authorised in 12 EEA countries. Names it is sold under:

  • Austria · Lariam
  • Belgium · Lariam
  • Cyprus · Eloquine
  • Finland · Lariam
  • France · Lariam
  • United Kingdom (Northern Ireland) · Lariam, Mefloquine
  • Italy · Lariam
  • Luxembourg · Lariam
  • Netherlands · Lariam
  • Norway · Lariam
  • Portugal · Mephaquin Lactab
  • Sweden · Lariam

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f8df70d5-930c-4ad3-b903-bcb933e54d11
GET /v1/drugs/f8df70d5-930c-4ad3-b903-bcb933e54d11?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "250",
  "substance": "MEFLOQUINE HYDROCHLORIDE",
  "productndc": "62135-973",
  "dosage_form": "TABLET",
  "dea_schedule": null,
  "strength_unit": "mg/1",
  "application_number": "ANDA076175",
  "marketing_category": "ANDA"
}
API referenceMCP serverPlans

See everything about mefloquine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console